Table 5.
Association of PUFA intake on HRQoL in elderly COPD patients (n=298)
Variable | Total PUFA | N3 PUFA | N6 PUFA | |||
---|---|---|---|---|---|---|
Coefficient±SE | p-value | Coefficient±SE | p-value | Coefficient±SE | p-value | |
Crude | 0.838±0.186 | <0.001 | 0.797±0.221 | <0.001 | 0.865±0.186 | <0.001 |
Model 1 | 0.627±0.197 | 0.002 | 0.528±0.224 | 0.019 | 0.673±0.201 | 0.001 |
Model 2 | 0.592±0.193 | 0.002 | 0.481±0.215 | 0.026 | 0.642±0.198 | 0.001 |
Model 3 | 0.532±0.186 | 0.005 | 0.354±0.175 | 0.045 | 0.532±0.186 | 0.005 |
Multivariable linear regression analyses were performed after log-transforming the value of total, N3, and N6 PUFA because of its left-skewed distribution. HRQoL was measured using European Quality of Life-5 Dimensions. Model 1 was adjusted for age and sex; model 2 was additionally adjusted for body mass index, smoking status, and alcohol consumption; and model 3 was additionally adjusted for residence, education, total calorie intake, and predicted FEV1%.
PUFA, polyunsaturated fatty acid; HRQoL, health-related quality of life; COPD, chronic obstructive pulmonary disease; N3, omega-3; N6, omega-6; SE, standard error; FEV1, forced expiratory volume in 1 second.